Your browser doesn't support javascript.
loading
Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505).
Gerber, David E; Urbanic, James J; Langer, Corey; Hu, Chen; Chang, I-Fen; Lu, Bo; Movsas, Benjamin; Jeraj, Robert; Curran, Walter J; Bradley, Jeffrey D.
Afiliação
  • Gerber DE; Harold C. Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: david.gerber@utsouthwestern.edu.
  • Urbanic JJ; University of California San Diego, San Diego, CA.
  • Langer C; University of Pennsylvania, Philadelphia, PA.
  • Hu C; Johns Hopkins University, Baltimore, MD; RTOG Foundation, Philadelphia, PA.
  • Chang IF; Bristol-Myers Squibb, New York, NY.
  • Lu B; Thomas Jefferson University, Philadelphia, PA.
  • Movsas B; Henry Ford Hospital, Detroit, MI.
  • Jeraj R; University of Wisconsin Carbone Cancer Center, Madison, WI.
  • Curran WJ; Emory University Medical Center, Atlanta, GA.
  • Bradley JD; Washington University School of Medicine, St. Louis, Mo.
Clin Lung Cancer ; 18(3): 333-339, 2017 05.
Article em En | MEDLINE | ID: mdl-27923550

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Etoposídeo / Quimiorradioterapia / Imunoterapia / Neoplasias Pulmonares / Anticorpos Monoclonais Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Etoposídeo / Quimiorradioterapia / Imunoterapia / Neoplasias Pulmonares / Anticorpos Monoclonais Idioma: En Ano de publicação: 2017 Tipo de documento: Article